WeedLife News Network

It wasn’t too long ago that if you asked somebody what CBD was, they would look at you with a puzzled expression on their face. Today, CBD is on everyone’s lips, dominating the conversation on medical cannabis and its therapeutic effects and being touted as a health supplement at nutrition stores. It can also be purchased online and found in department stores, drug stores, grocery stores, gas stations and, of course, dispensaries.

With CBD’s popularity comes a learning curve for the discerning consumer. In order to find the best product for their needs, consumers need to know the terminology around CBD products.

First, What Is CBD?

CBD, or cannabidiol, is a non-euphoric cannabinoid found in both hemp and high-THC cannabis. Cannabinoids are a closely related group of chemical compounds, which work synergistically together and with the other chemical compounds that make up the cannabis plant. CBD can be used for symptom management for things such as anxiety, certain types of seizures, inflammation and pain. It also has been found to have value in cosmetic use.

It’s worth noting that much CBD on the market today is derived from hemp, rather than cannabis, because hemp is federally legal. Hemp and cannabis are the same species, cannabis sativa, but they’re separated by an arbitrary legal definition that defines hemp as having less than 0.3% THC when tested.

Understanding CBD

Many people like to say CBD is not psychoactive, but that would be incorrect. “Psychoactive” is a term used to describe a substance that changes a mental state by affecting the brain and nervous system. Though CBD will not cause euphoria or intoxication, it may change a person’s level of anxiety or depression, which in turn would affect their perception of the world around them.

In 2020, Norman’s medical marijuana industry quickly proved to be an emerging market.

The marijuana industry locally and statewide more than doubled its revenue compared to 2019, as the state’s new industry grew to one of the biggest marijuana markets in the country. While some attribute the industry’s success to the COVID-19 pandemic, others suggest medical marijuana would’ve seen continual growth in 2020 regardless.

Below is a summary of the industry’s growth in 2020 in Norman and statewide, its impact on local residents and what experts expect for medical marijuana in 2021.

Local revenue increase

Norman’s industry saw a boom in sales throughout much of 2020, particularly in the summer months.

According to data from the Oklahoma Tax Commission, Norman dispensaries produced $33.6 million in total revenue in 2020, doubling the $16.1 million dispensaries put out in 2019. Norman dispensaries also remitted more than $2.9 million in city and state sales tax in 2020.

A total ban on smokable hemp products makes little sense. The state has time to think this through and come up with a better solution.

A few weeks back, I wrote a post entitled “California Tries Again with CBD“, in which I discussed a new piece of legislation (AB-45) introduced to ostensibly provide a regulatory framework for the manufacture and sale of certain hemp-derived products. Those products include foods or beverages that contain cannabidiol (CBD). In that post, I mentioned that provisions in AB-45 contain bans on smokable hemp products, and in this post I’d like to jump a little further into this provision and whether it has any chance of becoming law.

Currently, AB-45 provides in part:

Unless explicitly approved by the federal Food and Drug Administration, industrial hemp shall not be included in products in any of the following categories:

. . .

Cannabis advocates have long called for allowing people to treat pain with marijuana rather than opioids. A new study shows that this is exactly what happens when you give people the freedom to choose between the two.

The study, published in The British Medical Association Journal, found that in United States counties, medical or recreational cannabis is available for purchase, the number of opioid-related deaths declined.

While the declines occurred with all types of opioids, including prescription painkillers, they found a profound decrease in deaths associated with synthetic opioids. 

“While the associations documented cannot be assumed to be causal, they suggest a potential association between increased prevalence of medical and recreational cannabis dispensaries and reduced opioid-related mortality rates,” the researchers wrote. “This study highlights the importance of considering the complex supply side of related drug markets and how this shapes opioid use and misuse.”

What the research shows

University of California-Davis professor Greta Hsu and Yale University professor Balázs Kovács worked together on the study. The pair looked at data from 812 counties in 23 states where the law allowed legal cannabis sales.

A House legislative committee on Monday debated two bills legalizing cannabis for recreational use in New Mexico, ultimately sending one along to the House Taxation Revenue Committee and tabling the other. 

HB 12 and HB 17 both would have legalized cannabis for recreational use in New Mexico while taking different approaches to licensing and regulation. The bills were compared and debated at length in hearings on Saturday and Monday. 

Democratic state Reps. Tara Lujan of Santa Fe and Roger Montoya of Velarde cosponsored the latter bill, which was tabled on a 7-4 vote, effectively killing it, though committee members encouraged them to offer amendments incorporating aspects of their bill into HB 12. 

The version of the Cannabis Regulation Act that emerged from the committee provides a plan for regulating production, distribution and sales of cannabis to adults ages 21 and older through a new Cannabis Control Division at the state Regulation and Licensing Department. 

It would also permit home growing with no plant count limit, and cannabis licenses — unlike New Mexico liquor licenses — would not be limited in number, could not be bought and sold and would require annual renewal. 

More than 18,000 workers are employed in Michigan’s marijuana industry, nearly double the number of cannabis jobs in the state a year ago, according to a new cannabis industry jobs report.

“There are now more cannabis workers than cops in Michigan,” said the fifth annual Leafly jobs report, released Tuesday. “In a state known for its auto industry, the number of cannabis workers is now roughly equal to the number of auto repair mechanics.”

Leafly, a Seattle-based marijuana media organization, uses available revenue and labor figures from licensing records to compile the annual report.

The best thing to do is to start with the basics. Gradually, you can move to more complex gear if you want to take your experience to the next level.

Concentrates are perhaps the trickiest form of cannabis you may come across. They are highly potent, and the consumption techniques are also complicated, whether you choose to smoke, vape, or dab. Still, using the right gear can make things a lot simpler for beginners, and you get better with practice and experience. The choice of equipment depends on several factors, which you need to consider when making your decision. Here are some helpful tips that you can follow while choosing the right gear for using concentrates.

Size and convenience

You will want to choose your concentrate gear according to your skill level. For a beginner, the simplest is the best because it will be easy to handle and use. Handling the potency and managing dosages for cannabis concentrates may be challenging enough for you, so you’ll want gear that is easy to use. Size also matters because larger pieces can be difficult to operate. Thankfully, there are lots of choices in bongs and bubblers, from large, table-top pieces to small, handheld ones.

Photo by Bill Oxford/Getty Images

Method of consumption

The next factor to consider is the method of consumption and the form of concentrate. When it comes to types of concentrates, there are many, from wax to shatter, resin, rosin, oil, hash, and more. Consumption methods also vary depending on your preference, and the equipment you use will differ accordingly.Alzheimer's Disease And Marijuana: What You Need To Know

By building a positive presence on social media, stock traders may unwittingly become attracted to a company.

Can a social media profile improve a company’s stock performance? The market saw what happened on Reddit boards with GameStop stock as traders chatted with each other about shorting the stock. Could a company that is active on social media, without any specific call to action regarding the stock, influence the interest in the company’s stock?

“If investors are looking to determine the popularity of a company or demand for its product, they can analyze the brand’s social media. If they see great engagement on posts, high account following, or virality, high re-share of a brand’s content, they may make an assumption that this company will be even a greater hit with consumers in the future,” said mega influencer Amra Beganovich.

“Investors can use software to track social media performance and reveal organic growth giving them greater confidence to invest in an expanding brand visibility and product popularity.” Beganovich has built from scratch over two million followers on social and is one of the founders of A&E, a digital agency ranking #1 on Google for competitive keywords like “top 100 tech influencers.”

Awesomepova recently issued a social media traction report that specifically looked at cannabis companies. Four companies were listed as top performers in December and they were Trulieve (OTC:TCNNF), Canopy Growth (NASDAQ: CGC), Charlotte’s Web (OTC: CWBHF) and cbdMD (NYSE: YCBD). Two companies were listed as having an honorable mention and they were Aurora Cannabis (NYSE: ACB) and Harvest Health & Recreation (OTC: HRVSF).

As a dispensary builder, one of the most common questions we’re asked is: How much does it cost to build a cannabis dispensary? We usually answer that question with about 20 questions of our own, because no two cannabis retail stores are the same.

Even when we build dispensaries for national companies that specify the same design and finishes, we face unique circumstances in each state that affect overall project costs. Ultimately, that cost can range anywhere from $350,000 to $3.5 million.

Medical cannabis legalization can come in many forms, and as such, not all medical cannabis programs, like dispensaries, are created equal.

On one end of the medical cannabis policy spectrum are countries that only permit limited use of CBD medicines/products.

Technically those countries have legalized medical cannabis, however, only in an extremely limited fashion.

On the other end of the spectrum are countries that have fully embraced cannabis as a medicine and patients have safe access to it, complete with the legal right to cultivate cannabis at home.

One component of a medical cannabis program is particularly important at least when it comes to fighting the opioid epidemic.

Legalizing and taxing commercial cannabis sales in Virginia could generate between $154 and $308 million by the fifth year of sales. Here’s what else you might find interesting.

On February 5th, state lawmakers voted to legalize cannabis in Virginia and establish a recreational market. Both chambers’ initiative would legalize possession of an ounce of marijuana or less, and begin the process of expunging certain cannabis-related misdemeanors on July 1st. Retail sales are predicted to start in 2024, per the plans of both the House and Senate.

Virginia already has a medical marijuana program, but it’s limited compared to most states. Even so, the medical program is expected to be valued at $50 million in sales by 2024, and the adult-use market is poised to grow even bigger.

Here’s what you need to know about the newly introduced adult-use legislation in Virginia:

The vote passed through the Virginia General Assembly on February 5th

Both chambers passed the bill to legalize cannabis for adult use at the beginning of February. The bill was introduced by Senator Adam Ebbin, who said “I think that Virginia is on a path to an equitable legalization plan for marijuana. There have been a few bumps, but I’m hopeful that we’ll have a polished bill we can agree upon in the next few weeks,” said Sen. Ebbin.

The House passed the bill 55-42

House Democrats were in favor of the bill, while Republicans were opposing it. The House’s version of the bill would maintain all cannabis criminal penalties until January 1st, 2024, when the first adult-use retail sale is set to take place.

This Valentine’s Day, expensive dinners at fancy restaurants are out, and sexy, stoned nights at home are in—and that’s fine with us. For couples who enjoy using cannabis together, the possibilities are endless. Plus, let’s be real: plenty of us would rather receive something weed-related instead of a cliché heart shaped box of chocolates from the drug store.

Whether you’re planning on indulging in some serious self-love on Valentine’s Day or looking to spoil your lover, we’ve got you covered with gift ideas ranging from tame to…definitely not so tame.

Kush Queen Love Potion No. 9 CBD Bath Bomb, $20.00

The Kush Queen bath bomb is jam-packed with 200mg of CBD, sure to melt any aches and pains away to gear you up for sexy time. The aromas will get you in the mood, too. It contains a range of essential oils for the perfect scent: Bergamont, sweet orange, ylang-ylang, cedarwood, patchouli, and lavender. If you want to take your gift to the next level, you can get The CBD Love Kit, which includes the bath bomb along with CBD lube and massage oil.

More than half of North Carolinians who responded to a recent survey said that they supported the legalization of recreational marijuana in their state, according to a poll conducted by Elon University. The survey found even stronger support for reducing penalties for marijuana offenses and the legalization of cannabis for medicinal purposes.

The survey found that 54% of adults in North Carolina supported the legalization of recreational marijuana, while about a third (34%) were opposed. The remaining 12% said that they didn’t know. The results showed a marked increase in support compared to 2017, when about 51% said that they were opposed to recreational marijuana legalization and 45% said they supported the move.

“Opposition to recreational marijuana legalization fell substantially over the last three years,” said Jason Husser, director of the Elon Poll and associate professor of political science. “I suspect this is due in large part to the wave of states that have passed legalization measures. Medical marijuana legalization remains broadly supported in every demographic group we examined.”

Support Varies By Age, Political Party

Support for legalizing recreational marijuana varied significantly among different age groups and by political party affiliation, with younger respondents, Democrats, and those associated with neither major party showing a greater likelihood to approve the change.

“We found a major generational gap for recreational marijuana legalization with those under 44 being about twice as likely as those 65 or older to support legalization,” Husser said. “Notably, these large generational differences do not extend to support for medical marijuana and lowering criminal penalties. Most Republicans also supported reducing penalties and legalizing medical marijuana.”

New York legislators have introduced a bill that would legalize smokable hemp flower, something that was conspicuously left out of the state’s recent suite of hemp regulations. 

Earlier this week, A2682/S4340 passed the state legislature’s Health Committee and advanced to the Codes Committee. The bill, introduced by State Assemblywoman Donna Lupardo and State Sen. Michelle Hinchey, proposes direct sales of hemp flower from producers to consumers. 

Last fall, we spoke with Empire Standard CEO Kaelan Castetter, who said that much of the backlash against the state’s hemp and CBD regulations was focused on the flower ban. “It’s a bright spot in the marketplace,” he said, “and many people have been setting up to grow [flower].”

Allan Gandelman, president of the New York Cannabis Growers & Processors Association provided the following statement:

“The New York Cannabis Growers & Process Association is a coalition of New York based hemp growers and processors who actively advocate for laws and regulations that support and encourage a vibrant, diverse, and sustainable cannabis industry. We express our strong support for the passage of A-2682/S-4340 and our members recognize the urgent need to repair harmful regulations proposed by the NYS Department of Health that would prohibit the sale of hemp flower to the consumer.

Momentum is building towards a decision concerning legalising medical cannabis and industrial hemp in The Bahamas.

The Bahamas is a country within the Lucayan Archipelago of the West Indies in the Atlantic, north of Cuba. Home to around 389,000, it consists of more than 700 islands and cays.

The Bahamas Prime Minister Hubert Minnis  said last week that his Government is in the process of completing legislation for the legalization of medicinal marijuana in the country to table in Parliament. The comments were made at the commissioning ceremony for the Hope Town Shoreline Stabilization Project according to the Office Of The Prime Minister’s Facebook page.

Legalising medical cannabis has strong support in the island nation, including from the Caribbean Association of Pharmacists (CAP).

“Now, we feel that cannabis is a medicine; that all the scientific data going back decades has already proven this,” said CAP President Dr Marvin Smith.

Sales of marijuana concentrates shot up more than 40 percent last year and accounted for a larger share of the overall cannabis market, as consumers became more comfortable with the intricate process of dabbing and new technology has made the products easier to use.

In addition, some consumers are moving away from vape products because of respiratory-related health concerns and turning to concentrates such as wax, hash and shatter, according to industry insiders.

State Rep. Yadira Caraveo says her proposal to limit the potency of marijuana sold recreationally in Colorado was just in its beginning stages. But when draft legislation was recently leaked and prominent figures in the state’s cannabis industry created an uproar, the measure started unraveling. 

Now, Caraveo, a Thornton Democrat and pediatrician, is backing off parts of the measure and loosening the restrictions in what’s left.

“Given the pushback that we’ve had overall on the bill,” she said, “we really want to streamline it and focus it on the things that we think absolutely need to happen this year.”

A new study that looks at blood pressure in older adults with hypertension saw a connection between cannabis use and a reduction in systolic and diastolic blood pressure, findings that are significant for those who suffer from the two ailments. 

The study, titled “Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study” carried out by Ran Abuhasira, M.D., of Ben-Gurion University of the Negev and his team, located in Israel, and published in the European Journal of Internal Medicine in January of this year, looked at patients 60 or older with hypertension and medical cannabis prescriptions. The study then monitored their rates of use and their blood pressure. The patients then underwent blood tests, monitoring, and other medical procedures during the course of three months, as they actively used cannabis to manage their conditions. 

The researchers looked at a total of 26 cannabis patients, of which exactly 53.8 percent were female. The findings showed that, while no big changes were seen in the ECG exam results of the patients study, blood pressure was overall lower in those with hypertension who were consistently using medical cannabis. 

“The proportion of normal dippers changed from 27.3 percent before treatment to 45.5 percent afterward,” the study said regarding the percentage of people whose blood pressure levels dipped. “No significant changes were seen in the different metabolic parameters assessed by blood tests, anthropometric measurements, or ECG exam.”

“Medical cannabis use is increasing rapidly in the past several years, with older adults being the fastest growing group,” it continued. “Nevertheless, the evidence for cardiovascular safety of cannabis use is scarce. The aim of this study was to assess the effect of cannabis on blood pressure, heart rate, and metabolic parameters in older adults with hypertension.”

Will These 3 Cannabis Stocks Give Investors More Market Value

Currently, in 2021, there has been more money invested in marijuana stocks and the industry as a whole. As the cannabis industry gears up for the potential of federal cannabis reform there is great excitement behind it. Because of this investors have been making sure they don’t miss a good opportunity. This positive sentiment has created some more upward momentum causing some marijuana stocks to reach new all-time highs.